Australia has a rich research environment, highly experienced investigators and research professionals, coupled with excellent health care infrastructure and a strong intellectual property regime.
Australia has almost as long-a-history of conducting clinical trials to a high standard as clinical research practice itself.
Australia has a rich research environment, highly experienced investigators and research professionals, coupled with excellent health care infrastructure and a strong intellectual property regime. Many Australian investigators and researchers are world leaders in their field. There are many attractive features of research and development in Australia. Notably, current efforts to simplify the ethics approval process is ongoing. A new clinical trials website and a register for clinical trial participants also aim to facilitate the recruitment of subjects in Australia. Australia does not require full regulatory submission and approval for the conduct of clinical trials. Rather, it uses a notification process only which significantly reduces the time required to set up and start a clinical trial.
The Australian government also provides financial support to research through the R&D tax incentive, which provides either ‘cash back’ or tax offsets to R&D spend – ask us how to make the most of this incentive.
Central Nervous System 43%
Medical Devices 26%
|Number of Personnel||60, including administrative personnel|
|Hospital Records Language||English|
|Electronic Hospital Records||Australia is in the process of implementing electronic hospital records. This is already in place for some hospitals|
|Site Network||Australia is home to numerous highly experienced clinical trial sites, including public hospitals, private hospitals and other organizations. Currently, there is not yet an established accreditation system for clinical trial sites in Australia. However, the Australian National Health & Medical Research Council (NHRMC) is developing a system that recognizes sites that are ‘ready, willing and able’ to perform high quality clinical trials.|
|In-country services||Full Service|
|GDP – per capita (US $)||$65,400|
|Health Expenditures||9.4% of GDP|